Masahiro Shuda

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 24, 2025
Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.

Joseph L Collura, Kuan Cheok Lei, Mitalee Chandra

|May 23, 2025
Disruption of ATR Signaling by Epstein-Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin.

Gabriella Zarkovic, Phillip Ziegler, Jennifer Hye-Rim Lee

|Jul 11, 2024
Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1.

Kuan Cheok Lei, Nalini Srinivas, Mitalee Chandra

|May 05, 2023
Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice.

Rui Sun, Siying Guo, Yoko Shuda

|Dec 27, 2022
Merkel cell polyomavirus small T antigen is a viral transcription activator that is essential for viral genome maintenance.

Kyle Rapchak, Shiva D Yagobian, Jackson Moore

|Sep 19, 2019
Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.

Alexis Harold, Yutaka Amako, Junichi Hachisuka

Pageof 1

Frequent Collaborators

2 joint publications

Yuan Chang

2 joint publications

Kuan Cheok Lei

2 joint publications

Mitalee Chandra

2 joint publications

Thibault Kervarrec